The impact of disease‐drug interactions on drug development and clinical practice

This commentary notes that alteration of disease status by the administered drug(s) is the major cause for disease-drug interaction(s), and that early identification and proper management of such interactions would facilitate drug development and improve clinical practice.


British Journal of Clinical Pharmacology